Shares of Progyny (NASDAQ: PGNY) were crashing 30.1% lower as of 11:22 a.m. ET on Thursday. The steep decline came after the fertility benefits provider disclosed in a regulatory filing that it was losing an unnamed major client.
Progyny said that the client “confirmed they had no issues of concern over the course of its multiyear relationship with the Company, including member satisfaction or quality of service or outcomes.” It also noted that there have been no disputes with the large client.
How much will the loss of this client hurt Progyny?
The major client’s services agreement with Progyny will remain in effect through the rest of 2024. As a result, Progyny doesn’t expect any negative impact on its financial results for the current fiscal year.
However, the client generated 12% of Progyny’s revenue over the six months ending June 30, and 13% over the 12 months ending Dec. 31, 2023. Progyny stated that the client makes up an undisclosed smaller percentage of its adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA).
The company will definitely feel some effects of the loss next year. Still, though, Progyny said that it continues to project an increase in overall member count in both 2024 and 2025.
Is Progyny stock a good pick to buy on the dip?
Some brave investors could be interested in scooping up shares of Progyny after its latest bad news. However, I think the prudent thing to do is remain on the sidelines until there’s more clarity on the company’s growth prospects.
Should you invest $1,000 in Progyny right now?
Before you buy stock in Progyny, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Progyny wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Nvidia made this list on April 15, 2005… if you invested $1,000 at the time of our recommendation, you’d have $694,743!*
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*.
See the 10 stocks »
*Stock Advisor returns as of September 16, 2024
Keith Speights has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Progyny. The Motley Fool has a disclosure policy.
Why Progyny Stock Is Crashing Today was originally published by The Motley Fool
